top of page

CGRP Medications: A Breakthrough in Migraine Treatment

Migraines are a debilitating neurological condition that affects millions of people worldwide. For those who suffer from chronic migraines, finding effective treatment options can be challenging. However, in recent years, a new class of medications called CGRP inhibitors has emerged as a breakthrough in migraine treatment. In this blog post, we will explore CGRP medications and their role in managing migraines, offering hope to individuals seeking relief from this debilitating condition.

CGRP (calcitonin gene-related peptide) is a neuropeptide that plays a significant role in the development of migraines. It is released during a migraine attack and contributes to the dilation of blood vessels and the transmission of pain signals. CGRP inhibitors work by blocking the activity of CGRP or its receptor, thereby reducing the frequency and severity of migraines.

Types of CGRP Medications:

There are currently three FDA-approved CGRP medications available for the prevention of migraines:

1. Aimovig (erenumab):

Aimovig is a monthly self-injectable medication that targets the CGRP receptor. It has been shown to significantly reduce the number of migraine days experienced by patients.

2. Emgality (galcanezumab):

Emgality is a monthly self-injectable medication that targets CGRP itself. It has demonstrated efficacy in reducing the frequency of migraines and improving patients' quality of life.

3. Ajovy (fremanezumab):

Ajovy is available as a monthly or quarterly self-injectable medication that also targets CGRP. It has shown effectiveness in reducing the number of migraine days and improving patient outcomes.

Benefits of CGRP Medications:

CGRP medications have revolutionized migraine treatment by offering several benefits:

1. Efficacy:

Clinical trials have shown that CGRP inhibitors can significantly reduce the frequency, duration, and severity of migraines in patients who experience chronic migraines.

2. Fewer Side Effects:

CGRP medications are generally well-tolerated, with minimal side effects reported. Common side effects include injection site reactions, constipation, and mild allergic reactions.

3. Convenience:

CGRP medications are self-administered through subcutaneous injections, allowing patients to manage their treatment at home. This offers convenience and flexibility compared to other preventive migraine treatments.

4. Improved Quality of Life:

By reducing the frequency and severity of migraines, CGRP medications can significantly improve patients' quality of life, allowing them to engage in daily activities more effectively. Considerations and Consultation:

While CGRP medications have shown promising results, it's important to note that they may not be suitable for everyone. As with any medication, it is crucial to consult with a healthcare professional to determine the most appropriate treatment plan for your specific condition. They can assess your medical history, evaluate potential interactions with other medications, and discuss potential side effects.

CGRP medications have emerged as a groundbreaking treatment option for individuals suffering from chronic migraines. By targeting the CGRP pathway, these medications effectively reduce the frequency and severity of migraines, providing much-needed relief for patients. If you experience chronic migraines, it is essential to consult with a healthcare professional to discuss the potential benefits of CGRP medications and determine the best course of action for managing your migraines. With ongoing advancements in migraine research, CGRP medications offer hope for a brighter future for migraine sufferers.


Deen, M., Correnti, E., Kamm, K., Kelderman, T., Papetti, L., Rubio-Beltrán, E., Vigneri, S., Edvinsson, L., & Maassen Van Den Brink, A. (2017). Blocking CGRP in migraine patients – a review of pros and cons. The Journal of Headache and Pain, 18(1). Enter

You sent

6 views0 comments


bottom of page